-
Thematic Analysis
NewAdvertising Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Advertising has been caught up in the artificial intelligence (AI) frenzy and will be one of the industries most disrupted by AI. Generative AI is reshaping advertisers’ practices through tailored, effective ads and dynamic campaigns that evolve according to consumer response. As a result, the relationship between technology, artists, and brands paying for campaigns will profoundly change over the coming years. There is a real concern that advertisers will divert their money into AI-generated art rather than paying artists and...
-
Analyst Opinions
NewLuxury Travel – Key Trends and Market Analysis by Destinations, Challenges and Opportunities, 2024 Update
Luxury Travel Market Report Overview The luxury travel market includes lodging, airlines, travel agencies, and destinations. The luxury travel industry is anticipated to benefit from the growing number of high-net-worth individuals as this will help tourists take advantage of and enjoy upmarket products and services on subsequent trips. Post the relaxation of COVID-19-induced travel restrictions, the luxury travel industry has reinforced its outlook and started prioritizing customer experiences rather than material belongings. In addition to embracing sustainability and responsible travel...
-
Analyst Opinions
NewMobile World Congress (MWC) 2024 – Startups Race for Digital Change
GlobalData's latest report, "MWC 2024: Startups Race for Digital Change," dives into the innovation trends showcased by startup exhibitors at MWC 2024. With a focus on AI's pivotal role, it highlights how AI startups are shaping industry innovation and attracting investor interest. Additionally, it explores fintech, digitalization, IoT, and healthtech startups' contributions. By delving into the latest advancements, unique offerings, and venture capital activities of over 40 startups, this report serves as a valuable resource for stakeholders seeking to navigate...
-
Product Insights
NewLikelihood of Approval Analysis for Adrenal Gland Disorders
Overview How likely is it that the drugs in Adrenal Gland Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenal Gland Disorders Overview Adrenal gland disorders comprise various conditions impacting...
-
Product Insights
NewLikelihood of Approval Analysis for Refractory Chronic Lymphocytic Leukemia (CLL)
Overview How likely is it that the drugs in Refractory Chronic Lymphocytic Leukemia (CLL) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Refractory Chronic Lymphocytic Leukemia (CLL) Overview Refractory chronic lymphocytic...
-
Product Insights
NewLikelihood of Approval Analysis for Lipid Storage Disorders (Lipidoses)
Overview How likely is it that the drugs in Lipid Storage Disorders (Lipidoses) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lipid Storage Disorders (Lipidoses) Overview Lipid storage disorders, or lipidoses,...
-
Product Insights
NewLikelihood of Approval Analysis for Bone Metastasis
Overview How likely is it that the drugs in Bone Metastasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bone Metastasis Overview Bone metastasis occurs when cancer cells spread from their...
-
Product Insights
NewLikelihood of Approval Analysis for Autism Spectrum Disorder (ASD)
Overview How likely is it that the drugs in Autism Spectrum Disorder (ASD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Autism Spectrum Disorder (ASD) Overview Autism Spectrum Disorder (ASD) is...
-
Product Insights
NewLikelihood of Approval Analysis for Back Pain
Overview How likely is it that the drugs in Back Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Back Pain Overview Back pain, a prevalent discomfort, originates from various sources,...